title: [Therapeutic management of antiphospholipid antibody syndrome in pregnancy].
abstract: The antiphospholipid syndrome, recently described, associates thromboembolism risks, fetal losses and thrombopenia. An obstetrical survey of this syndrome implies previous analyses of maternal and fetal risks and leads to treatment which may associate low doses of aspirin, heparin, corticoids. This complex syndrome offers the best example of materno-fetal medicine usefulness.
authors.affiliation: Service de Gynécologie Obstétrique, Hôpital Bichat, Paris.
authors.forename: P
authors.initials: P
authors.lastname: Edelman
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000453:epidemiology / Q000276:immunology / Q000628:therapy*; D001241:Aspirin / Q000627:therapeutic use; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology / Q000628:therapy*; D011256:Pregnancy Outcome; D012307:Risk Factors; D013921:Thrombocytopenia / Q000209:etiology; D013923:Thromboembolism / Q000209:etiology
chemical_list: D000305:Adrenal Cortex Hormones; D006493:Heparin; D001241:Aspirin
vernacular_title: Prise en charge thérapeutique du syndrome des anticorps antiphospholipides pendant la grossesse.